Two recent compounding case studies describe treatments that helped adults with persistent drooling as well as cats with behavioral issues.

PCCA's Chief Scientific Officer Gus Bassani provides an important and exciting update regarding the work of our Research and Development department over the last 18 months.

Maria Carvalho, Manager of PCCA Science, explains scientific poster presentations and why they are important when it comes to peer-reviewed research of pharmacy compounding

Maria Carvalho discusses the latest versions of the USP (43rd edition) and NF (38th edition), as well as the corresponding USP Compounding Compendium, recognizing the importance of several proprietary PCCA bases

Nat Jones, one of PCCA's Clinical Compounding Pharmacist, discusses the importance of naltrexone and how compounders can use Low-Dose Naltrexone therapy, especially with dermatological health challenges.

Maria Carvalho, Manager of PCCA Science, provides an in-depth look at the science behind Ellage, the first ever anhydrous compounding base developed specifically for vaginal delivery of medications.

Maria Carvalho briefly discusses and provides 8 of the published, peer-reviewed stability studies of compounded medications with PCCA's SuspendIt. These studies were conducted by the researchers at Xavier University of Louisiana.

Members of PCCA's Clinical Services and PCCA Science teams provide a review of some of the research into the morbidity, mortality and pathogenicity of SARS-CoV-2. The information gathered is based on the best scientific evidence currently available regarding potential treatments. They also take the time to explore some potential non-prescription and prescription options based on their research.

Maria Carvalho, PharmD, MRPharmS, PhD, Manager of PCCA Science, provides an exciting update regarding treatment of oral lichen planus, a formulation study for surgical wound healing and a whole lot more in this PCCA Science Update!

Nat Jones of PCCA's Clinical Services Team discusses the clinical data about the efficacy of Permeation-enhanced topical pain therapy (PETPT) or transdermal pain therapy. He provides a brief history of transdermal pain therapy and evidence of the levels of efficacy PETPT has within medicine.